Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Alnylam Pharmaceuticals
(NQ:
ALNY
)
166.36
USD
+1.29 (+0.78%)
Official Closing Price
Updated: 5:18 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
711,600
Open
165.35
Bid (Size)
160.00 (1)
Ask (Size)
180.00 (1)
Prev. Close
165.07
Today's Range
165.35 - 171.01
52wk Range
84.97 - 175.41
Shares Outstanding
100,522,411
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Alnylam Launches “Alnylam P5x25” Strategy for Planned Transition to a Top Five Biotech in Market Capitalization Over Next Five Years
January 10, 2021
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its new 5-year strategy “Alnylam P5x25” focused on the Company’s planned transition to a top-5...
From
Business Wire News Releases
Alnylam Reports Positive Topline Results from HELIOS-A Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis with Polyneuropathy
January 07, 2021
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the HELIOS-A Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development...
From
Business Wire News Releases
Performance
YTD
+29.87%
+29.87%
1 Month
+20.27%
+20.27%
3 Month
+14.42%
+14.42%
6 Month
+5.05%
+5.05%
1 Year
+39.40%
+39.40%
More News
Read More
Alnylam to Webcast Presentation at 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021
From
Business Wire News Releases
Alnylam Appoints Tolga Tanguler Chief Commercial Officer and Also Announces New CEMEA, Medical Affairs, and Compliance Leaders
December 21, 2020
From
Business Wire News Releases
Alnylam Announces 2021 Product and Pipeline Goals and Provides Program Updates at R&D Day
December 15, 2020
From
Business Wire News Releases
Alnylam to Webcast Virtual R&D Day
December 08, 2020
From
Business Wire News Releases
CENTOGENE and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)
December 08, 2020
From
GlobeNewswire News Releases
First Week of September 17th Options Trading For Alnylam Pharmaceuticals (ALNY)
Today 11:29 EST
Tags
Stocks
From
Market News Video
Alnylam Issues 2nd Annual Patient Access Philosophy Report Highlighting Broad Access to the Company’s Approved Therapies
December 07, 2020
From
Business Wire News Releases
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
January 11, 2021
Tags
PFE
TLRY
AZN
From
Benzinga
Notable Friday Option Activity: ALNY, LULU, UI
January 08, 2021
Tags
Stocks
From
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.